{"id":"CHEMBL10316","canonicalSmiles":"c1ccc2c(c1)OCC(C1=NCCN1)O2","inchiKey":"HPMRFMKYPGXPEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDAZOXAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dl-idazoxan","Idazoxan","NSC-759867","RX-781094","Racemic idazoxan"],"crossReferences":{"PubChem":["104171177","144203724","170466595","26751897","90341761"],"Wikipedia":["Idazoxan"],"drugbank":["DB12551"],"chEBI":["5862"]},"childChemblIds":["CHEMBL543467"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0002009","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1078261","canonicalSmiles":"CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1","inchiKey":"QPCVHQBVMYCJOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Detrunorm","Detrunorm xl","Mictonorm"],"synonyms":["Mictonetten","NSC-172140","Propiverine","Propiverine hydrochloride"],"crossReferences":{"PubChem":["50125813"],"drugbank":["DB12278"],"chEBI":["8493"]},"childChemblIds":["CHEMBL2359059"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for urinary incontinence and polyuria and has 1 investigational indication."}
{"id":"CHEMBL1159524","canonicalSmiles":"O=C(O)[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"AEMOLEFTQBMNLQ-QIUUJYRFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCURONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03156"],"chEBI":["28860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116583","canonicalSmiles":"N=C=N","inchiKey":"VPKDCDLSJZCGKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isocyanic acid (hnco)","Methanediylidenediamine"],"childChemblIds":["CHEMBL3301667"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1190232","canonicalSmiles":"COc1ccc2nc3cc(Cl)ccc3c(NC(C)CCCN(CCCl)CCCl)c2c1","inchiKey":"UKOBAUFLOGFCMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1190232","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02240"],"chEBI":["37595"]},"childChemblIds":["CHEMBL3217099"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200421","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM TC 99M MEBROFENIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110555","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Choletec","Technetium tc-99m mebrofenin"],"synonyms":["99mtc-mebrofenin","Technetium (99Mtc) Mebrofenin","Technetium (99mtc) mebrofenin","Technetium tc 99m mebrofenin","Technetium tc-99m mebrofenin kit"],"crossReferences":{"DailyMed":["technetium%20tc-99m%20mebrofenin%20kit"],"DrugCentral":["5119"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987 and has 1 investigational indication."}
{"id":"CHEMBL1200629","canonicalSmiles":"CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]","inchiKey":"VEPSYABRBFXYIB-PWXDFCLTSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"VECURONIUM BROMIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201219","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Musculax","Norcuron","Vecuronium bromide"],"synonyms":["NSC-759184","ORG NC 45","ORG-NC 45","Pancuronium bromide impurity, vecuronium bromide -","Vecuronium bromide"],"crossReferences":{"DailyMed":["vecuronium%20bromide"],"PubChem":["144206024","170465295"],"chEBI":["9940"]},"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_0005323"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200682","canonicalSmiles":"O=C([O-])CCCO.[Na+]","inchiKey":"XYGBKMMCQDZQOZ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"SODIUM OXYBATE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1342","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xyrem"],"synonyms":[".gamma.-hydroxybutyrate sodium salt","Catabate","NSC-84223","Oxybate sodium","Sodium oxybat","Sodium oxybate","Sodium oxybutyrate","WY-3478"],"crossReferences":{"DailyMed":["sodium%20oxybate"],"DrugCentral":["4566"],"PubChem":["144206424"],"Wikipedia":["Sodium_oxybate"],"drugbank":["DB09072"]},"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["MONDO_0021107","EFO_0005203","EFO_0005687","HP_0001337","EFO_0004777","MONDO_0018044","EFO_0003843","EFO_0004698","Orphanet_2131","Orphanet_93961","MONDO_0005180","MONDO_0004975","MONDO_0016158","MONDO_0007079","EFO_0003918","EFO_0003108","EFO_0007462","EFO_0004540"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for narcolepsy-cataplexy syndrome and narcolepsy and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201391","canonicalSmiles":"CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21","inchiKey":"XWLXKKNPFMNSFA-HGQWONQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENIVASTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simvastatin acid","Simvastatin carboxylic acid","Simvastatin hydroxy acid","Tenivastatin"],"crossReferences":{"drugbank":["DB14714"]},"childChemblIds":["CHEMBL487720","CHEMBL2107785"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201467","drugType":"Small molecule","blackBoxWarning":true,"name":"SYNTHETIC CONJUGATED ESTROGENS, B","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enjuvia"],"synonyms":["CE-10","Estrogens, conjugated synthetic b","Estrogens,conjugated synthetic b","Synthetic conjugated estrogens, b"],"crossReferences":{"DailyMed":["estrogens,%20conjugated%20synthetic%20b"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_1000096","EFO_0003922"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for menopause and atrophy. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201568","drugType":"Protein","blackBoxWarning":false,"name":"PEGFILGRASTIM","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neulasta","Neulasta sureclick"],"synonyms":["Chs-1701","Fulphila","Granulocyte colony-stimulating factor pegfilgrastim","Lupifil-p","MYL-1401H","Neupopeg","Nyvepria","Peg-filgrastim","Pegfilgrastim","Pegfilgrastim (neulasta)","Pegfilgrastim biosimilar - lupin","Pegfilgrastim for bioassay","Pegfilgrastim-apgf","Pegfilgrastim-bmez","Pegfilgrastim-cbqv","Pegfilgrastim-jmdb","Pegfilgrastim-ljfd","Ql-0605","Ql0605","TPI-120","Udenyca","Ziextenzo"],"crossReferences":{"DailyMed":["pegfilgrastim","pegfilgrastim-bmez","pegfilgrastim-cbqv","pegfilgrastim-jmdb"],"DrugCentral":["4986"],"Wikipedia":["Pegfilgrastim"]},"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0003859","MONDO_0003890","EFO_0000571","EFO_0000681","EFO_0000756","EFO_1000231","EFO_1000657","EFO_0005952","EFO_1001951","EFO_0000565","EFO_1001952","EFO_0000096","EFO_0000544","MONDO_0002974","MONDO_0008903","EFO_0008528","EFO_0000514","Orphanet_654","EFO_0000198","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_0002939","MONDO_0004986","MONDO_0008315","EFO_1000238","EFO_0005537","EFO_0000233","EFO_0000574","EFO_0001378","MONDO_0009348","MONDO_0004192","EFO_0002913","MONDO_0007254","Orphanet_790","EFO_1001469","HP_0001915","MONDO_0002087","EFO_0004252","MONDO_0021063","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","MONDO_0001475","EFO_1001974","MONDO_0001657","EFO_0000183","MONDO_0002083","EFO_0000616","EFO_0006859","EFO_0000403","MONDO_0007576","EFO_0000222","EFO_1001953","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0006861","HP_0002653","MONDO_0005147","EFO_0000702","MONDO_0018906","MONDO_0024880","EFO_0000691","MONDO_0004643","EFO_0000181"],"count":72},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 4 approved and 56 investigational indications."}
{"id":"CHEMBL1201576","drugType":"Antibody","blackBoxWarning":true,"name":"RITUXIMAB","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mabthera","Mabthera rituxan","Rituxan"],"synonyms":["ABP-798","ABP798","Bi-695500","Blitzima","CT-P10","Gp2013","HS-006","HS-006 (RITUXIMAB BIOSIMILAR)","HS006","IDEC-102","IDEC-C2B8","Pf-05280586","R-105 IDEC-102","RG-105","RHCACD20MA","Riabni","Ritemvia","Rituximab","Rituximab (genetical recombination)","Rituximab biosimilar - celltrion","Rituximab-abbs","Rituximab-arrx","Rituximab-boehringer ingelheim","Rituximab-ct-p10","Rituximab-pfizer","Rituximab-pvvr","Ruxience","SAIT-101","SAIT101","Truxima","Tuxella","Usp mab 001, monoclonal igg1","Zuberitamab"],"crossReferences":{"DailyMed":["rituximab","rituximab-abbs","rituximab-pvvr"],"DrugCentral":["4975"],"Wikipedia":["Rituximab"]},"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0001423","EFO_0005952","MONDO_0018896","EFO_0006803","EFO_1000318","MONDO_0015760","EFO_0000339","EFO_0000096","EFO_1000956","EFO_0002690","EFO_0003884","EFO_0004991","EFO_0004288","EFO_0000198","MONDO_0013730","MONDO_0019465","EFO_0001642","EFO_1001946","EFO_0009538","MONDO_0008315","EFO_0000384","EFO_0008610","MONDO_0019139","EFO_0007187","EFO_1001365","MONDO_0044889","EFO_0003032","EFO_0008520","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000550","MONDO_0015564","Orphanet_84","EFO_0003086","EFO_0007498","MONDO_0021117","EFO_0000255","MONDO_0004095","MONDO_0003541","EFO_1001486","EFO_0009606","EFO_0009562","EFO_0003100","MONDO_0005180","EFO_1000630","EFO_0004289","MONDO_0004695","EFO_0007208","EFO_0004826","EFO_0000183","EFO_0005140","EFO_0000707","MONDO_0002083","Orphanet_797","EFO_0000616","EFO_0003897","EFO_0000772","EFO_1001779","EFO_1000868","EFO_0000765","MONDO_0019457","HP_0000093","EFO_0000403","EFO_0003898","EFO_0003929","EFO_0000222","MONDO_0018170","MONDO_0000870","EFO_0004599","EFO_0000304","EFO_0005297","Orphanet_238510","EFO_0007359","MONDO_0018906","EFO_0000557","MONDO_0024880","EFO_0004540","EFO_0000729","MONDO_0000873","EFO_0003869","EFO_0003780","EFO_1000131","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0007160","Orphanet_365","EFO_0002612","HP_0001871","MONDO_0019088","EFO_0000389","EFO_0004255","EFO_0004244","EFO_0007332","Orphanet_98878","EFO_0000094","EFO_1000749","EFO_0008522","EFO_0004719","EFO_0009441","EFO_0002689","EFO_0005761","EFO_0004145","EFO_0000220","EFO_1001466","EFO_1000157","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_1000784","EFO_1001050","EFO_0003840","MONDO_0001023","MONDO_0044917","EFO_1001051","MONDO_0002334","EFO_0000699","MONDO_0009348","Orphanet_282","MONDO_0005090","MONDO_0000432","Orphanet_232","EFO_0000768","MONDO_0044887","EFO_0003778","EFO_1001469","EFO_1001264","HP_0001915","EFO_0000209","MONDO_0002462","EFO_1002048","MONDO_0001718","HP_0000083","EFO_0005531","EFO_1000783","EFO_0000474","EFO_0000769","EFO_0004254","EFO_0003860","EFO_0003144","Orphanet_309144","MONDO_0020743","MONDO_0001437","EFO_0000717","EFO_0010580","EFO_0002617","EFO_0000685","EFO_0000621","EFO_1001383","EFO_0000311","HP_0012664","MONDO_0005301","EFO_0000095","MONDO_0001549","MONDO_0005147","EFO_0000191"],"count":157},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 11 approved and 123 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201745","canonicalSmiles":"CC(C)(Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1)C(=O)[O-].C[N+](C)(C)CCO","inchiKey":"JWAZHODZSADEHB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE FENOFIBRATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL981","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trilipix"],"synonyms":["ABT-335","Choline fenofibrate","Fenofibric acid choline salt"],"crossReferences":{"DailyMed":["choline%20fenofibrate"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0001645","Orphanet_79211","EFO_0000319","EFO_0009321","Orphanet_309005"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for cardiovascular disease and has 4 investigational indications."}
{"id":"CHEMBL1201784","canonicalSmiles":"CCCCCCOC(=O)CCC(=O)CN","inchiKey":"RYQOILLJDKPETL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXAMINOLEVULINATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexaminolevulinate"],"crossReferences":{"drugbank":["DB06261"]},"childChemblIds":["CHEMBL1201785"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for carcinoma and has 4 investigational indications."}
{"id":"CHEMBL1236602","canonicalSmiles":"O=C(O)/C=C/c1c[nH]cn1","inchiKey":"LOIYMIARKYCTBW-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Imidazoleacrylic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Imidazoleacrylic Acid"],"crossReferences":{"PubChem":["111433","11532901","144210176","50107206","56422865","90341479"],"drugbank":["DB01971"],"chEBI":["30817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276342","canonicalSmiles":"CO[C@@]1(NC(=O)CSC[C@@H](N)C(=O)O)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21","inchiKey":"JSDXOWVAHXDYCU-VXSYNFHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMINOX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefminox","Cefminox sodium"],"crossReferences":{"drugbank":["DB09062"]},"childChemblIds":["CHEMBL3184670"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1324","canonicalSmiles":"Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1","inchiKey":"MIQPIUSUKVNLNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLCAPONE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," Canada"," Ireland"," Portugal"," Australia"],"classes":["Hepatotoxicity"],"year":1998},"tradeNames":["Tasmar","Tolcapone"],"synonyms":["RO 40-7592","RO-40-7592","RO-407592","Tolcapone"],"crossReferences":{"DailyMed":["tolcapone"],"PubChem":["144206516","144212731","170465081","50126317"],"Wikipedia":["Tolcapone"],"drugbank":["DB00323"],"chEBI":["63630"]},"linkedTargets":{"rows":["ENSG00000093010"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0003096","EFO_0003768","Orphanet_271861","EFO_0000621","EFO_0007046","HP_0001399","MONDO_0002046","EFO_0003890","MONDO_0005180","EFO_0004699","MONDO_0043510","EFO_0004242","MONDO_0007079"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for hepatic failure and parkinson disease and has 10 investigational indications. It was withdrawn in European Union,  Canada,  Ireland,  Portugal and  Australia initially in 1998 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1356238","canonicalSmiles":"[O-][n+]1ccccc1S","inchiKey":"FGVVTMRZYROCTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57260394"],"drugbank":["DB06815"],"chEBI":["36584"]},"childChemblIds":["CHEMBL1200471","CHEMBL2364542"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1410","canonicalSmiles":"CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1","inchiKey":"FBWNMEQMRUMQSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONOXYNOL 9","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["C-film","Conceptrol","Delfen","Double check","Duragel","Emko","Gygel","Gynol 11","Gynol ii","Intercept","Ortho-creme","Ortho-forms","Prelude","Semicid","Today","Today sponge"],"synonyms":["Igepal co-630","NSC-758941","Nonoxinol 9","Nonoxinolum 9","Nonoxynol 9","Nonoxynol-9","Nonoxynol-9.5","Nonylphenoxypolyethoxyethanol","Norfox np-9","Peg-9 nonyl phenyl ether","Tergitol np-9"],"crossReferences":{"PubChem":["26749924"],"Wikipedia":["Nonoxynol-9"],"drugbank":["DB06804"],"chEBI":["53775"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1414320","canonicalSmiles":"CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"ONWXNHPOAGOMTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUXIBUZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-757866","Suxibuzone"],"crossReferences":{"PubChem":["11112710","124882557","144204166","144209550","144213095","170465972","56463081"],"Wikipedia":["Suxibuzone"],"drugbank":["DB13232"],"chEBI":["32173"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL141966","canonicalSmiles":"CCOCn1c(SC2CCCCC2)c(C(C)C)c(=O)[nH]c1=O","inchiKey":"JKXLRLDPSLZEDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TNK-6123","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TNK-6123"],"crossReferences":{"drugbank":["DB07184"],"chEBI":["62748"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1449676","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CC(O)CCl","inchiKey":"IPWKIXLWTCNBKN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORNIDAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tiberal"],"synonyms":["NSC-95075","Ornidazole","RO 7-0207","RO-7-0207","RO-70207"],"crossReferences":{"PubChem":["144204133","170466243","855702"],"drugbank":["DB13026"],"chEBI":["75176"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL1451179","canonicalSmiles":"CCCC(O)C(CC)CO","inchiKey":"RWLALWYNXFYRGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOHEXADIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-12 insect repellent","Ethohexadiol","Ethyl hexanediol","Ethylhexanediol","Etohexadiol","NSC-3881","Repellent 612"],"crossReferences":{"PubChem":["144209201","144213570","170465521","17389337"],"Wikipedia":["Etohexadiol"],"drugbank":["DB13826"],"chEBI":["34273"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1551","canonicalSmiles":"C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"RUDATBOHQWOJDD-UZVSRGJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URSODIOL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actigall","Cholurso","Destolit","Urdox","Urso","Urso 250","Urso forte","Ursodiol","Ursofalk","Ursogal"],"synonyms":["NSC-683769","Ursodeoxycholate","Ursodeoxycholic acid","Ursodesoxycholic acid","Ursodiol","Ursonorm"],"crossReferences":{"DailyMed":["ursodiol"],"PubChem":["11532904"],"Wikipedia":["Ursodiol"],"drugbank":["DB01586"],"chEBI":["9907"]},"childChemblIds":["CHEMBL2028234"],"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["EFO_1000905","EFO_0003095","EFO_0004228","EFO_1001249","EFO_0000373","EFO_1001486","EFO_1001951","EFO_0002950","EFO_0005240","Orphanet_733","MONDO_0005180","EFO_0003884","MONDO_0015183","HP_0002910","HP_0012378","EFO_0000400","EFO_0000685","HP_0001952","EFO_0004799","EFO_0004210","EFO_1000864","MONDO_0001751","EFO_0001074","EFO_0004267","HP_0002014","MONDO_0019072","EFO_0001073","EFO_0001422","Orphanet_399","MP_0001845","EFO_0004268","EFO_0004220","EFO_1001068","EFO_0001421","MONDO_0005148"],"count":35},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for primary biliary cirrhosis and biliary liver cirrhosis and has 22 investigational indications."}
{"id":"CHEMBL158","canonicalSmiles":"C[C@H]1[C@H](NC(=O)/C(=N\\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O","inchiKey":"WZPBZJONDBGPKJ-VEHQQRBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZTREONAM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azactam","Aztreonam","Cayston"],"synonyms":["Azactam","Azonam","Aztreon","Aztreonam","NSC-646279","NSC-758913","Nebactam","Primbactam","SO 26776","SQ 26776","SQ-26776"],"crossReferences":{"DailyMed":["aztreonam"],"Wikipedia":["Aztreonam"],"drugbank":["DB00355"],"chEBI":["161680"]},"childChemblIds":["CHEMBL3833340"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 7 approved and 6 investigational indications."}
{"id":"CHEMBL1615993","canonicalSmiles":"COc1ccc2[nH]c(-c3cccc(F)c3)cc(=O)c2c1OP(=O)(O)O","inchiKey":"ZDWFMAHQGDEALT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSLINANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CVM-1118","CVM-1118 FREE ACID","Cvm-1118","Foslinanib","TRX-818","TRX-818 FREE ACID","Trx 818"],"childChemblIds":["CHEMBL1277519"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL168640","canonicalSmiles":"COC(=O)N[C@H](C(=O)NCCCC[C@@H](CO)N(CC(C)C)S(=O)(=O)c1ccc(N)cc1)C(c1ccccc1)c1ccccc1","inchiKey":"QAHLFXYLXBBCPS-IZEXYCQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PPL-100","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8122","MX-100","PL 100 (PHARMACEUTICAL)","PL-100","PPL 100","Pl-100","Ppl-100","TMB-607","Tmb-607"],"crossReferences":{"drugbank":["DB05961"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1790041","canonicalSmiles":"CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1","inchiKey":"VMXUWOKSQNHOCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANITIDINE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-757851","Ranitidine","Tritec","Zantac"],"crossReferences":{"DailyMed":["ranitidine%20hydrochloride"],"PubChem":["170465134"],"TG-GATEs":["86"],"Wikipedia":["Ranitidine"],"drugbank":["DB00863"]},"childChemblIds":["CHEMBL2110372","CHEMBL2111286"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["Orphanet_2314","EFO_0005592","HP_0012735","EFO_0000681","EFO_0005252","MONDO_0007254","MONDO_0043839","EFO_0009579","EFO_0000540","EFO_0003948","HP_0004398","MONDO_0015277","EFO_1000961","EFO_0000280","MONDO_0004658","EFO_0001645","EFO_0009658","EFO_0003929","EFO_0004607","MONDO_0008315","EFO_1001355","EFO_0000311","EFO_0008533","EFO_0009454","MONDO_0005301","EFO_0000764","MONDO_0044917","EFO_0001378","EFO_1001095"],"count":29},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 5 approved and 20 investigational indications."}
{"id":"CHEMBL1909282","canonicalSmiles":"O=C(O)Cc1csc(-c2ccc(Cl)cc2)n1","inchiKey":"APBSKHYXXKHJFK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENCLOZIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Hepatotoxicity"],"year":1970},"tradeNames":[],"synonyms":["Fenclozic acid","I.C.I. 54,450","ICI-54450"],"crossReferences":{"PubChem":["144205372","170466565","29216130"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom and  United States initially in 1970 due to Hepatotoxicity."}
{"id":"CHEMBL1963683","canonicalSmiles":"CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COc1ccccc1","inchiKey":"WSNODXPBBALQOF-VEJSHDCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFLUPROST","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Saflutan","Zioptan"],"synonyms":["AFP-168","MK-2452","Tafluprost"],"crossReferences":{"DailyMed":["tafluprost"],"Wikipedia":["Tafluprost"],"drugbank":["DB08819"],"chEBI":["66899"]},"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 3 approved indications."}
{"id":"CHEMBL2005186","canonicalSmiles":"CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1","inchiKey":"GKHIVNAUVKXIIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELUMOSUDIL","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Belumosudil","KD-025","KD025","Rock2 inhibitor kd025","SLx-2119","Slx-2119 free base"],"crossReferences":{"PubChem":["103905007"]},"childChemblIds":["CHEMBL4802130"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000404","EFO_1001494","EFO_0000768","EFO_0001421","EFO_0000676"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for graft versus host disease and has 6 investigational indications."}
{"id":"CHEMBL2062266","canonicalSmiles":"COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=C(O)C(O)C(O)C(=O)O","inchiKey":"ZGSZBVAEVPSPFM-FFHNEAJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROCODEINE BITARTRATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1595","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DF 118","DF-118","Dihydrocodeine bitartrate","Dihydrocodeine bitartrate cii","Dihydrocodeine hydrogen tartrate","Dihydrocodeine phosphate","Dihydrocodeine tartrate","Dihydroneopine","Drocode","NSC-117857"],"crossReferences":{"DailyMed":["dihydrocodeine%20bitartrate"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and is indicated for pain."}
{"id":"CHEMBL206815","canonicalSmiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO","inchiKey":"MAVDNGWEBZTACC-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRATASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apratastat","TMI-005","TMI-05"],"crossReferences":{"drugbank":["DB13020"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL207496","canonicalSmiles":"N[C@H](COc1cncc2nc(-c3ccncc3)ccc12)Cc1c[nH]c2ccccc12","inchiKey":"DQIXTEDFNFZMCM-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207496","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07204"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2093999","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC(=O)[C@H]4CC(=NOCCN)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"MPYLDWFDPHRTEG-IFVNMTGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISTAROXIME","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E,Z)-Istaroxime","Istaroxime","PST-2744"],"linkedTargets":{"rows":["ENSG00000163399","ENSG00000018625","ENSG00000137731","ENSG00000069849","ENSG00000174437","ENSG00000105409","ENSG00000132681","ENSG00000129244","ENSG00000143153"],"count":9},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000373","HP_0031273"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105566","canonicalSmiles":"CC(Cc1ccccc1)NCCC#N","inchiKey":"IQUFSXIQAFPIMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENPROPOREX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Femproporex","Fenorex","Fenproporex","J268.797F"],"crossReferences":{"drugbank":["DB01550"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105967","canonicalSmiles":"O=C(CCCCCCCC(=O)NCCO)NCCO","inchiKey":"PAHZPHDAJQIETD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADELMIDROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adelmidrol","NSC-27132"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107966","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYGLYCONATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Maxon"],"synonyms":["MAS-1","Polyglyconate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108134","drugType":"Small molecule","blackBoxWarning":false,"name":"POLOXAMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lutrol f","Pluracare","Pluronic"],"synonyms":["Poloxamer"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108175","drugType":"Unknown","blackBoxWarning":false,"name":"ANTIHEMOPHILIC FACTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alphanate","Bioclate","Haemate-p","Helixate","Hemofil m","Humafac","Humate-p","Koate-hp","Kogenate","Monoelate-p","Profilate heat-treated","Profilate hp","Profilate osd","Profilate sd"],"synonyms":["Antihemophilic factor","Antihemophilic factor (human)","Antihemophilic factor human","Antihemophilic factor viii human","Antihemophilic factor, human","Antihemophilic factor,human","Antihemophilic human plasma","Factor viii (human)","Factor viii, human","Factorate","Human coagulation factor viii"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108380","drugType":"Protein","blackBoxWarning":false,"name":"LIATERMIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gdnf liatermin","Liatermin","R-methugdnf"],"linkedTargets":{"rows":["ENSG00000151892"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180"],"count":1},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108459","drugType":"Antibody","blackBoxWarning":false,"name":"FONTOLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fontolizumab","HUZAF"],"linkedTargets":{"rows":["ENSG00000111537"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109334","drugType":"Antibody","blackBoxWarning":false,"name":"INEBILIZUMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uplizna"],"synonyms":["Inebilizumab","Inebilizumab-cdon","MEDI-551","MEDI551"],"crossReferences":{"DailyMed":["inebilizumab-cdon"]},"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0001642","EFO_0000403","EFO_0000540","EFO_0000311","MONDO_0005301","EFO_0000095","MONDO_0017287","EFO_0004256","EFO_1001993","EFO_0000574","EFO_0001378","EFO_0007332","EFO_0004991","EFO_0000717"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for immune system disease and neuromyelitis optica and has 11 investigational indications."}
{"id":"CHEMBL2109488","drugType":"Antibody","blackBoxWarning":false,"name":"INCLACUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inclacumab","LC-1004-002","LC1004-002","RG1512","RO-4905417","RO4905417"],"linkedTargets":{"rows":["ENSG00000174175"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0000612","EFO_0004265"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109512","drugType":"Antibody","blackBoxWarning":false,"name":"MCS-110","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCS-110","Mcs-110"],"linkedTargets":{"rows":["ENSG00000184371"],"count":1},"linkedDiseases":{"rows":["MONDO_0001056","EFO_0000756","MONDO_0007254"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109610","drugType":"Antibody","blackBoxWarning":false,"name":"HUMIK-BETA-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUMIK-BETA-1","Humik-beta-1"],"linkedTargets":{"rows":["ENSG00000100385"],"count":1},"linkedDiseases":{"rows":["EFO_0001060","EFO_0007316","MONDO_0019469"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110560","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTETATE CALCIUM TRISODIUM YB","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL1200698"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL223339","canonicalSmiles":"NC[C@H](c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1","inchiKey":"HWVGILTYGZFGLR-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223339","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07858"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2272076","canonicalSmiles":"Cc1c(C(=O)c2cnn(C)c2O)ccc(S(C)(=O)=O)c1C1=NOCC1","inchiKey":"IYMLUHWAJFXAQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOPRAMEZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212758"],"drugbank":["DB14826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2316582","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1","inchiKey":"TZKBVRDEOITLRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLVEREMBATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-824","D-824 DIMESYLATE","GZD-824","GZD-824 DIMESYLATE","Gzd-824 dimesylate","HQP-1351","HQP-1351 DIMESYLATE","HQP1351","HQP1351 DIMESYLATE","Hqp1351","Olverembatinib","Olverembatinib dimesylate"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000339","Orphanet_44890"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL233406","canonicalSmiles":"O=S(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"PMZURENOXWZQFD-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SULFATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glaubers Salt","Golytely"],"synonyms":["Anhydrous sodium sulfate","E-514(I)","E-514(II)","E514","INS NO.514(I)","INS NO.514(II)","INS-514(I)","INS-514(II)","Mirabilite","NSC-403914","NSC-71192","Sodium bisulfate","Sodium sulfate","Sodium sulfate decahydrate"],"crossReferences":{"DailyMed":["sodium%20sulfate","sodium%20sulfate%20anhydrous"],"DrugCentral":["4212"],"PubChem":["144208243"],"Wikipedia":["Sodium_sulfate"],"drugbank":["DB09472"],"chEBI":["32149"]},"childChemblIds":["CHEMBL3989856"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for constipation."}
{"id":"CHEMBL2364623","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O.O=S(=O)(O)O","inchiKey":"SFTBRKHJMASSAP-BGJNVEJLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PLAZOMICIN SULFATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1650559","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zemdri"],"synonyms":["ACHN-490","Plazomicin hemipentasulfate","Plazomicin sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for pyelonephritis and urinary tract infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL237127","canonicalSmiles":"Cc1ccc(O)cc1Nc1ccnc2cc(-c3csc(C=O)n3)ccc12","inchiKey":"VKQPTVJDZIILPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237127","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07832"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2435707","canonicalSmiles":"CCCCOc1c(OCCCC)c(=O)c1=O","inchiKey":"XBRWELTXMQSEIN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUARIC ACID DIBUTYL ESTER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dibutyl squarate","NSC-113489","Squaric acid dibutyl ester","Squaric acid dibutylester"],"crossReferences":{"drugbank":["DB12223"],"chEBI":["53612"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL24563","canonicalSmiles":"CCCCCCCCCO","inchiKey":"ZWRUINPWMLAQRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NONANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Nonanol","Nonan-1-ol"],"crossReferences":{"PubChem":["144211186"],"Wikipedia":["1-Nonanol"],"drugbank":["DB03143"],"chEBI":["35986"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261723","canonicalSmiles":"O=C(N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)CO)OCc1ccccc1","inchiKey":"OACUXIVGLLCILS-ZEQRLZLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL261723","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01871"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267495","canonicalSmiles":"CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"XGZZHZMWIXFATA-UEZBDDGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALFURAFINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MT-9938","Nalfurafine"],"crossReferences":{"drugbank":["DB13471"]},"childChemblIds":["CHEMBL490665"],"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["EFO_0003884","EFO_0001421"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL277100","canonicalSmiles":"CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1","inchiKey":"QKDHBVNJCZBTMR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMAFLOXACIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," Germany"],"classes":["Hematological toxicity"," Hepatotoxicity"," Immune system toxicity"," Nephrotoxicity"],"year":1992},"tradeNames":[],"synonyms":["Omniflox","Temafloxacin"],"crossReferences":{"PubChem":["144206857"],"Wikipedia":["Temafloxacin"],"drugbank":["DB01405"],"chEBI":["77796"]},"childChemblIds":["CHEMBL2107495"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for bacterial disease. It was withdrawn in United States,  United Kingdom and  Germany initially in 1992 due to Hematological toxicity,  Hepatotoxicity,  Immune system toxicity and  Nephrotoxicity."}
{"id":"CHEMBL3039523","canonicalSmiles":"CCC[C@@H](N(NC(=O)c1cccc(OC)c1CC)C(=O)c1cc(C)cc(C)c1)C(C)(C)C","inchiKey":"LZWZPGLVHLSWQX-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VELEDIMEX","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INXN-1001","RG-115932","Veledimex"],"crossReferences":{"drugbank":["DB12170"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL320358","canonicalSmiles":"CCCCCCC(=O)O","inchiKey":"MNWFXJYAOYHMED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTANOATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Heptanoate","Heptanoic Acid","Heptanoic Acid Anion"],"crossReferences":{"PubChem":["144209028","144210660","17389663"],"Wikipedia":["Heptanoic_acid"],"drugbank":["DB02938"],"chEBI":["45571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL328827","canonicalSmiles":"Nc1nc(N)c2c(Sc3ccc(N4CCOCC4)cc3)cccc2n1","inchiKey":"CZLWCJRHDBTCGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL328827","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL329203","canonicalSmiles":"CNC(C)CC1CCCC1","inchiKey":"HFXKQSZZZPGLKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clopane","Cyclonarol","Cyclopentamine","Cyklosal","Sinos"],"crossReferences":{"Wikipedia":["Cyclopentamine"],"drugbank":["DB08999"]},"childChemblIds":["CHEMBL2107277"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544933","drugType":"Small molecule","blackBoxWarning":false,"name":"VS-4718","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PND-1186","SR-2516","VS-4718","Vs-4718"],"linkedTargets":{"rows":["ENSG00000169398"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000222","EFO_0000094","MONDO_0024880"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545059","canonicalSmiles":"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC.O=C(O)/C=C/C(=O)O","inchiKey":"KLRSDBSKUSSCGU-KRQUFFFQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALISKIREN FUMARATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1639","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tekturna"],"synonyms":["Aliskiren fumarate","Aliskiren hemifumarate","NSC-759185","SPP-100B","SPP100"],"crossReferences":{"DailyMed":["aliskiren%20hemifumarate"],"chEBI":["53777"]},"linkedTargets":{"rows":["ENSG00000143839"],"count":1},"linkedDiseases":{"rows":["EFO_0000712","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for hypertension and stroke. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545082","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7376","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-5568","Rg-7376"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL359744","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1.Cl","inchiKey":"MWWSFMDVAYGXBV-RUELKSSGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOXORUBICIN HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL53463","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adriamycin","Adriamycin Rdf","Adriamycin pfs","Caelyx","Doxil","Doxil (liposomal)","Doxorubicin hydrochloride","Doxorubicin hydrochloride (liposomal)","Myocet","Rubex"],"synonyms":["Adriablastina cs","Adriamycin, hydrochloride","Doxorubicin HCl","Doxorubicin citrate","Doxorubicin citric acid salt","Doxorubicin hcl","Doxorubicin hydrochloride","Doxorubicin liposomal complex of the hydrochloride","Doxorubicini hydrochloridum","Hydroxydaunomycin hydrochloride","Liposomal doxorubicin hydrochloride"],"crossReferences":{"DailyMed":["doxorubicin%20hydrochloride"],"PubChem":["144203601","144205614","144209681","170465451","17389199","49681823","49718188","50126368","855944"]},"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["EFO_0004708","EFO_0000637","EFO_0000558","EFO_0003859","EFO_0000681","EFO_1000231","EFO_0005952","EFO_1000984","EFO_1001951","EFO_1001952","EFO_1001935","EFO_0000588","EFO_0000096","EFO_0000564","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0002918","EFO_0000760","MONDO_0021054","EFO_0000198","EFO_1001968","EFO_1001946","MONDO_0004986","MONDO_0008315","MONDO_0002691","Orphanet_398934","EFO_1001365","EFO_0003032","MONDO_0044889","EFO_0000574","EFO_0001378","EFO_1000796","EFO_0001376","MONDO_0003175","MONDO_0007254","Orphanet_790","MONDO_0003541","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_0003968","EFO_1001974","MONDO_0017387","MONDO_0012825","EFO_0000183","MONDO_0002618","MONDO_0002083","EFO_0000616","EFO_0006859","EFO_0000765","EFO_1000314","EFO_0000403","EFO_1001042","EFO_0000222","MONDO_0000870","MONDO_0007576","EFO_1001953","EFO_0000304","MONDO_0011962","EFO_0000702","EFO_1001947","MONDO_0002367","MONDO_0018906","MONDO_0024880","MONDO_0000873","EFO_0003869","EFO_0001075","EFO_1000131","EFO_0005561","EFO_0000565","EFO_0000309","EFO_0007160","EFO_0000182","MONDO_0015540","EFO_0000094","Orphanet_654","EFO_1000595","EFO_0003893","MONDO_0004658","EFO_1000292","EFO_0000220","EFO_0000248","MONDO_0008170","MONDO_0005094","EFO_0000223","EFO_0000502","EFO_0009708","EFO_0007143","EFO_1001100","EFO_1000238","EFO_0005537","MONDO_0044917","EFO_0006544","EFO_0000569","MONDO_0009348","MONDO_0004192","MONDO_0015686","EFO_1001469","EFO_0000209","MONDO_0002087","EFO_0000305","MONDO_0001187","EFO_0003144","Orphanet_31112","EFO_0000239","EFO_1000158","EFO_0000437","MONDO_0002678","EFO_0000313","EFO_0000621","EFO_0003060","EFO_0000311","EFO_0000211","EFO_0006861","EFO_0000095","EFO_0006475","EFO_0000174","MONDO_0002621","EFO_1001936","MONDO_0020077","EFO_0000691"],"count":122},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 21 approved and 80 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL367746","canonicalSmiles":"Nc1nc2cc[nH]c2c(=O)[nH]1","inchiKey":"FFYPRJYSJODFFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-Deazaguanine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Deazaguanine"],"crossReferences":{"drugbank":["DB04356"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL371948","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@H](CCCCCCCCC(=O)OC[C@H]1O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]1O)[C@@H]2O","inchiKey":"CKSDYJASHNGOOS-KTXOUVACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02323"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833319","canonicalSmiles":"CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1","inchiKey":"FYDWDCIFZSGNBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REVEFENACIN","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Yupelri"],"synonyms":["GSK-1160724","GSK1160724","Revefenacin","TD-4208"],"crossReferences":{"DailyMed":["revefenacin"],"drugbank":["DB11855"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0006536","EFO_0001421","EFO_0000341"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for chronic obstructive pulmonary disease and airway obstruction and has 2 investigational indications."}
{"id":"CHEMBL3833407","canonicalSmiles":"CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](NC(=N)N)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O","inchiKey":"AWBXTNNIECFIHT-XZQQZIICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STREPTODUOCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3833338"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989834","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC","inchiKey":"YBWLTKFZAOSWSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVOSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avosentan","RO 67-0565","RO-67-0565","Ro670565","SPP-301","SPP301"],"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0000401"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL399121","canonicalSmiles":"COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O","inchiKey":"AIONOLUJZLIMTK-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HESPERETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-57654"],"crossReferences":{"PubChem":["11112384","11112385","124882313","26754195","56463566"],"Wikipedia":["Hesperetin"],"drugbank":["DB01094"],"chEBI":["28230"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL401842","canonicalSmiles":"N=C(N)NOCCNC(=O)Cc1c(Cl)ccc(NCC(F)(F)c2ccccc2)c1F","inchiKey":"DZEJHPMTDNDECN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401842","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07946"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4076124","canonicalSmiles":"CC(F)(F)c1cc(F)ccc1-c1sc2cc(O)ccc2c1Oc1ccc(/C=C/C(=O)O)cc1","inchiKey":"SJXNPGGVGZXKKI-NYYWCZLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4076124","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15362"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL41632","canonicalSmiles":"O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1","inchiKey":"UOWZUVNAGUAEQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRATRICOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,5,3'-triiodothyroacetate","Levothyroxine sodium impurity, triiodothyroacetic acid, or t3-acetic acid-","NSC-759294","T3-acetic acid","TRIAC","Tiracana","Tiratricol","Triiodothyroacetic acid"],"crossReferences":{"PubChem":["11112109","144203868","144213850","50100372","855525"],"Wikipedia":["Tiratricol"],"drugbank":["DB03604"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4170268","canonicalSmiles":"CCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2","inchiKey":"SVTKBAIRFMXQQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4170268","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14736"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL426815","canonicalSmiles":"NCc1ccc(NC(=O)C(=O)O)cc1","inchiKey":"RKILOCCSAVHHJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL426815","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02420"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL428880","canonicalSmiles":"O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1","inchiKey":"IMZMKUWMOSJXDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CROMOLYN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cromo-comod","Cromoglicate","Cromoglicic acid","Cromoglycate","Cromolyn","R03BC01"],"crossReferences":{"DailyMed":["cromolyn%20sodium"],"PubChem":["104171394","26751521","29215502","50103871","50123505"],"drugbank":["DB01003"],"chEBI":["59773"]},"childChemblIds":["CHEMBL74","CHEMBL4797821","CHEMBL351631"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 11 approved and 8 investigational indications."}
{"id":"CHEMBL4297064","canonicalSmiles":"CCN(CC)C(=O)C1(c2ccccc2)CC1CN.Cl","inchiKey":"XNCDYJFPRPDERF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MILNACIPRAN HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL259209","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dalcipran","Ixel","Milnacipran hydrochloride","Savella","Toledomin"],"synonyms":["Milnacipran hcl","Milnacipran hydrochloride","NSC-759806"],"crossReferences":{"DailyMed":["milnacipran%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0005687","HP_0003418"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for fibromyalgia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297384","canonicalSmiles":"CCn1ncc2c(NC3CCOCC3)c(-c3nnc(Cc4sc(C)nc4C)o3)cnc21","inchiKey":"AWDJJMXJUOHGLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-356278","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK356278","Gsk-356278","Gsk356278"],"crossReferences":{"drugbank":["DB12542"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297453","canonicalSmiles":"COc1c(C)cc2c(c1O)[C@@H]1[C@@H]3Cc4c(OC(C)=O)c(C)c5c(c4[C@H](CNC(=O)/C=C/c4cccc(C(F)(F)F)c4)N3[C@@H](O)[C@H](C2)N1C)OCO5","inchiKey":"VPAHZSUNBOYNQY-DLVGLDQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PM-00104","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PM00104","Pm-00104","Zalypsis"],"crossReferences":{"drugbank":["DB12454"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297515","canonicalSmiles":"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(CCOC(=O)OCCN5CCN(S(=O)(=O)c6ccc(OCC)c(-c7nc8c(CCC)nn(C)c8c(=O)[nH]7)c6)CC5)CC4)ccc3OCC)nc12","inchiKey":"MVYUCRDXZXLFSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LODENAFIL CARBONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Helleva","Lodenafil carbonate"],"crossReferences":{"drugbank":["DB11927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297946","drugType":"Unknown","blackBoxWarning":false,"name":"ENDOSTATIN, N-TERMINAL-MGGSHHHHH","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Endostar","Endostatin, n-terminal-mggshhhhh","N-terminal-mggshhhhh-endostatin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL4298107","drugType":"Unknown","blackBoxWarning":false,"name":"SOBI-003","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SOBI-003","SOBI003","Sobi-003","Sobi003"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL430893","canonicalSmiles":"COc1ccc([C@@H]2CNC(=O)C2)cc1OC1CCCC1","inchiKey":"HJORMJIFDVBMOB-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-ROLIPRAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-Rolipram","R-Rolipram"],"crossReferences":{"PubChem":["11112814","11113776","11113777","11113778","124882650","124882651"],"drugbank":["DB04149"],"chEBI":["40133"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL446435","canonicalSmiles":"CNC(=O)[C@H](Cc1ccc2ccccc2c1)N1CCC(=O)N(Cc2cnc3ccccc3c2)[C@@H](CC(C)C)C1=O","inchiKey":"COVPLULNDBDXTN-KYJUHHDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL446435","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04724"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594300","canonicalSmiles":"Br.Nc1nc(=O)c2c([nH]1)N[C@@H]1O[C@@H]3COP(=O)(O)O[C@@H]3C(O)(O)[C@@H]1N2.O.O","inchiKey":"GGLKTKQOHMCQHF-UNHNTEMGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSDENOPTERIN HYDROBROMIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2338675","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nulibry"],"synonyms":["ALXN1101 HBr","Fosdenopterin hydrobromide"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for sulfite oxidase deficiency due to molybdenum cofactor deficiency type a."}
{"id":"CHEMBL4594312","drugType":"Gene","blackBoxWarning":false,"name":"PRADEMAGENE ZAMIKERACEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EB-101","Eb-101","Prademagene zamikeracel"],"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594314","drugType":"Protein","blackBoxWarning":false,"name":"TIMBETASIN ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GBT-201","RGN-137","RGN-259","Rgn-137","Thymosin b4","Timbetasin acetate"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594540","drugType":"Unknown","blackBoxWarning":false,"name":"APVO-414","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APVO-414","APVO414","Apvo-414","ES-414","ES414","Es414","MOR-209","MOR209"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594548","drugType":"Antibody","blackBoxWarning":false,"name":"VULINACIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HLX-06","HLX06","Hlx06","Vulinacimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46439","canonicalSmiles":"N[C@H]1CCc2ccccc2[C@@H]1O","inchiKey":"IIMSEFZOOYSTDO-UWVGGRQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46439","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08654"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47","canonicalSmiles":"Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"GVJHHUAWPYXKBD-IEOSBIPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VITAMIN E","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Alpha Tocopherol","Aquasol E","Tocopherol"],"synonyms":["E307","Tocopherol","Vitamin E"],"crossReferences":{"DrugCentral":["3613"],"PubChem":["144204114","144206759","144209279","26754431","29215204","47193687"],"Wikipedia":["Alpha-Tocopherol"],"drugbank":["DB00163"],"chEBI":["18145"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL473489","canonicalSmiles":"O=C(/C=C(\\O)c1nnn[nH]1)c1c[nH]c2ccc(Cl)cc12","inchiKey":"LKVXXMOMTRBUQI-WCIBSUBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL473489","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03118"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL479960","canonicalSmiles":"NCC(=O)Nc1ccc(OCc2ccccc2)cc1","inchiKey":"YJPUATSIKWOSST-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL479960","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07099"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802187","drugType":"Antibody","blackBoxWarning":false,"name":"ADINTREVIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADG-20","ADG20","Adg20","Adintrevimab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL492399","canonicalSmiles":"COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1","inchiKey":"SNHCRNMVYDHVDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUBULIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Azixa"],"synonyms":["MPC-6827","MX-128495","Verubulin"],"crossReferences":{"drugbank":["DB05585"]},"childChemblIds":["CHEMBL3910844","CHEMBL2105697"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003833","EFO_0000519"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL493986","canonicalSmiles":"Cc1ccn(-c2ccc3c(c2)NCC3(C)C)c(=O)c1-c1ccc2nc(N)ncc2c1","inchiKey":"LHLGUOHREUTYTO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL493986","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL513301","canonicalSmiles":"COc1cc2c(N)nc(N3CCN(C(=O)OCC(C)(C)O)CC3)nc2c(OC)c1OC","inchiKey":"YNZXWQJZEDLQEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMAZOSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trimazosin"],"crossReferences":{"Wikipedia":["Trimazosin"],"drugbank":["DB09206"]},"childChemblIds":["CHEMBL3989848"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL522","canonicalSmiles":"NCc1ccccc1","inchiKey":"WGQKYBSKWIADBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminotoluene","Benzylamine"],"crossReferences":{"PubChem":["144211250","29217787"],"Wikipedia":["Benzylamine"],"drugbank":["DB02464"],"chEBI":["40538"]},"childChemblIds":["CHEMBL14186"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL558752","canonicalSmiles":"Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21","inchiKey":"YABJJWZLRMPFSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAF-265","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-265","NVP-RAF265","RAF265","Raf 265","Raf-265"],"crossReferences":{"PubChem":["137275908","50100093"],"drugbank":["DB05984"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000157764"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002617"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL562743","canonicalSmiles":"CC(=O)Nc1nc2c(s1)C(=O)NCCC2","inchiKey":"OYHOEDBNAJPFKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL562743","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["24807477"],"drugbank":["DB08776"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL585","canonicalSmiles":"Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1","inchiKey":"FNYLWPVRPXGIIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIAMTERENE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dyrenium","Dytac"],"synonyms":["NSC-639359","NSC-77625","SK&F 8542","SK&F-8542","SK-8542","Triamterene"],"crossReferences":{"DailyMed":["triamterene"],"PubChem":["104171252","11111878","11111879","124881638","124881640","144203834","144209219","144213150","170464706","17389703","26747035","26751552","50100356","50104154","50104155","85231255","855896","90341047"],"TG-GATEs":["101"],"Wikipedia":["Triamterene"],"drugbank":["DB00384"]},"linkedTargets":{"rows":["ENSG00000111319"],"count":1},"linkedDiseases":{"rows":["HP_0003124","HP_0000093","EFO_0001645","EFO_0004278","EFO_0009373","EFO_0000373","EFO_0000319","EFO_0000537","EFO_0003914","EFO_0001422","EFO_0004255","MONDO_0005148","EFO_0000400","EFO_0000668","EFO_0009452"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 8 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL660","canonicalSmiles":"NC12CC3CC(CC(C3)C1)C2","inchiKey":"DKNWSYNQZKUICI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMANTADINE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amantadine","Amantidine","NSC-341865","Symadine","Symmetrel","TCMDC-125869"],"crossReferences":{"DailyMed":["amantadine%20hydrochloride"],"PubChem":["104171100","11110715","124879107","144203619","170464860","26755640","26755641","50110918","50110919","90340894"],"Wikipedia":["Amantadine"],"drugbank":["DB00915"],"chEBI":["2618"]},"childChemblIds":["CHEMBL465617","CHEMBL1569","CHEMBL1445834"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003888","MONDO_0005090","EFO_0002610","HP_0000726","EFO_0005323","MONDO_0002679","EFO_0003843","EFO_0000546","EFO_1001175","EFO_0004220","EFO_0004247","MONDO_0100096","MONDO_0005301","EFO_0000544","HP_0001300","MONDO_0005180","EFO_1001402","EFO_0000712","EFO_1000632","EFO_0009854","EFO_0007328","EFO_0003047","MONDO_0043510","MONDO_0005148","EFO_0005411","EFO_1000860"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 7 approved and 18 investigational indications."}
{"id":"CHEMBL76370","canonicalSmiles":"CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12","inchiKey":"IKBKZGMPCYNSLU-RGVLZGJSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGASEROD","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2007},"tradeNames":["Zelmac"],"synonyms":["HTF 919","SDZ-HTF-919","Tegaserod"],"crossReferences":{"DailyMed":["tegaserod%20maleate"],"PubChem":["144205034","170466887","26749090"],"Wikipedia":["Tegaserod"],"drugbank":["DB01079"],"chEBI":["51043"]},"childChemblIds":["CHEMBL533819","CHEMBL1516474","CHEMBL4303321"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["MONDO_0002203","EFO_0003948","EFO_0000555","HP_0012450","HP_0002019","EFO_0008533"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 2 investigational indications. It was withdrawn in United States  in 2007 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL846","canonicalSmiles":"C=C1/C(=C\\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C[C@@H](O)C[C@@H]1O","inchiKey":"GMRQFYUYWCNGIN-NKMMMXOESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCITRIOL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcijex","Calcitriol","Dihydroxycholecalciferol","Dihydroxyvitamin D 3","Rocaltrol","Silkis","Topitriol","Vectical"],"synonyms":["1,25-dihydroxyvitamin d3","1,25-hydroxylated vitamin d","1alpha,25-dihydroxycholecalciferol","1alpha,25-dihydroxyvitamin d3","Calcitriol","RO 21-5535","RO-21-5535","RO-215535"],"crossReferences":{"DailyMed":["calcitriol"],"PubChem":["144205541","26719902","50110818"],"Wikipedia":["Calcitriol"],"drugbank":["DB00136"],"chEBI":["17823"]},"childChemblIds":["CHEMBL578780"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["HP_0002901","EFO_1001173","EFO_0003869","EFO_1001494","EFO_0000401","MONDO_0007254","EFO_0009451","EFO_0000274","MONDO_0002462","EFO_0003882","EFO_1001152","EFO_0007160","EFO_0002690","Orphanet_733","EFO_0003884","Orphanet_89936","EFO_0000673","EFO_0000676","EFO_0004193","EFO_0002617","EFO_1000158","EFO_0000198","EFO_0003888","EFO_0000616","EFO_0002618","HP_0000093","HP_0001919","EFO_1001006","EFO_0002424","EFO_0004194","EFO_0010445","EFO_0000384","EFO_0005221","MONDO_0008315","EFO_0003060","Orphanet_95","EFO_0000537","HP_0100806","EFO_0003868","EFO_0003854","EFO_1001121","MONDO_0005147","MONDO_0004979","Orphanet_2781"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 5 approved and 31 investigational indications."}
{"id":"CHEMBL8659","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)O","inchiKey":"ZQPPMHVWECSIRJ-KTKRTIGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["18:1(N-9)","9-octadecenoic acid, (z)-","9z-octadecenoic acid","FEMA NO. 2815","NSC-9856","Oleate","Oleic acid","Priolene 6936","Vopcolene 27","Wecoline oo"],"crossReferences":{"PubChem":["144204637","144209165","144213641","17388831","26732603","26752911","75221"],"Wikipedia":["Oleic_acid"],"chEBI":["16196"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
